Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes (No)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2008 by Wayne State University.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Wayne State University

ClinicalTrials.gov Identifier:

NCT00790348

First received: November 12, 2008

Last updated: NA

Last verified: October 2008

History: No changes posted

Tracking Information
First Received Date ^ICMJE	November 12, 2008
Last Updated Date	November 12, 2008
Start Date ^ICMJE	July 2008
Estimated Primary Completion Date	July 2009 (final data collection date for primary outcome measure)
Current Primary Outcome Measures ^ICMJE
Original Primary Outcome Measures ^ICMJE
Change History	No Changes Posted
Current Secondary Outcome Measures ^ICMJE
Original Secondary Outcome Measures ^ICMJE
Current Other Outcome Measures ^ICMJE
Original Other Outcome Measures ^ICMJE

Descriptive Information
Brief Title ^ICMJE	Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes
Official Title ^ICMJE	Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes
Brief Summary	The purpose of this study is to see the effect of Januvia on Ghrelin levels in patients with diabetes.
Detailed Description
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Time Perspective: Cross-Sectional
Biospecimen	Retention: Samples Without DNA Description: Serum of patients will be kept for future studies
Sampling Method	Probability Sample
Study Population	Patients with type 2 diabetes on oral agent that require Metformin or Januvia only
Condition ^ICMJE	Type 2 Diabetes
Intervention ^ICMJE
Study Group/Cohort (s)	1 Patients who on Januvia 2 Patients on Janumet (Combination of Januvia and Metformin) 3 Patients on Metformin
Publications *
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Recruiting
Estimated Enrollment ^ICMJE	45
Completion Date
Estimated Primary Completion Date	July 2009 (final data collection date for primary outcome measure)
Eligibility Criteria ^ICMJE	Inclusion Criteria: Patients with Type 2 diabetes Exclusion Criteria: Renal failure Pregnancy
Gender	Both
Ages	18 Years to 80 Years
Accepts Healthy Volunteers	No
Contacts ^ICMJE
Location Countries ^ICMJE	United States

Administrative Information
NCT Number ^ICMJE	NCT00790348
Other Study ID Numbers ^ICMJE	0709005250
Has Data Monitoring Committee	No
Responsible Party	Berhane Seyoum, Wayne State University
Study Sponsor ^ICMJE	Wayne State University
Collaborators ^ICMJE
Investigators ^ICMJE
Information Provided By	Wayne State University
Verification Date	October 2008
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top